Livongo Health
A new study conducted by the digital chronic disease management company highlighted engagement behaviors associated with stronger outcomes over 12 months.
Large health tech customers are more cautious and overwhelmed than ever, which means that many younger digital health startups will face an uphill battle selling their products in the months to come.
"Remote monitoring is here to stay," CEO Zane Burke said during yesterday's earnings call.
Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.
Although it's still operating in the red, the digital chronic disease management company logged 149% revenue growth in 2019.
Also: UCSD researchers employing Nvidia's AI; PatientWisdom's platform launching in Coastal Medical of Rhode Island.
While the price range, number of shares and timing of the listing are yet to be announced, a source tells MobiHealthNews that the startup is eyeing September for its IPO.
The company announced two-way integration today between its app and Apple, Fitbit and Samsung wearables.
According to a Wall Street Journal report, the digital chronic disease management company is eyeing a $1B-plus valuation.
Also: 23andMe's global privacy officer departs for global law firm; Oscar Health hires IBM Watson Health's corporate communications head.